Assessment of Acute Kidney Injury using MRI

Nicholas M Selby1,2, Susan T Francis3,4

  • 1Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Insights

Quantitative magnetic resonance imaging (MRI) offers promising ways to study acute kidney injury (AKI). This technique can assess kidney function and microstructure, aiding in understanding AKI progression and treatment response.

Area of Science:

  • Nephrology
  • Radiology
  • Biomedical Engineering

Background:

  • Acute kidney injury (AKI) affects millions globally, carrying significant morbidity and mortality.
  • Current treatments for AKI are limited, highlighting the need for better understanding and monitoring.
  • Quantitative MRI presents a non-invasive approach to assess kidney pathophysiology.

Purpose of the Study:

  • To review and interpret current preclinical and clinical studies using MRI for AKI assessment.
  • To discuss the potential of MRI in understanding AKI severity, progression, and treatment response.
  • To explore future directions for renal MRI in AKI research.

Main Methods:

  • Comprehensive literature review of preclinical and clinical studies utilizing quantitative MRI in AKI.
  • Analysis of various MRI techniques assessing kidney blood flow, perfusion, oxygenation, and microstructure.
  • Interpretation of findings across different AKI models and clinical settings.

Main Results:

  • Quantitative MRI enables detailed assessment of kidney function and tissue changes in AKI.
  • MRI can track AKI progression, recovery, and potential transition to chronic kidney disease (CKD).
  • The technique holds potential for non-invasive evaluation of therapeutic interventions in AKI.

Conclusions:

  • Quantitative MRI is a valuable tool for understanding AKI pathophysiology and clinical course.
  • Further research is needed to standardize MRI protocols and validate findings across diverse AKI contexts.
  • Renal MRI shows significant promise for improving AKI management and therapeutic development.